Rubaiy, Hussein N.
37  Ergebnisse:
Personensuche X
?
1

Transient Receptor Potential Canonical (TRPC) as a Therapeu..:

, In: Ion Channels as Targets in Drug Discovery,
Rubaiy, Hussein N. - p. 357-388 , 2024
 
?
5

T-type Ca2+ channel blocker mibefradil inhibits ORAI store-..:

Li, Pengyun ; Rubaiy, Hussein N. ; Chen, Guilan...
Journal of Molecular and Cellular Cardiology.  140 (2020)  - p. 26-27 , 2020
 
?
6

Mibefradil, a T‐type Ca2+ channel blocker also blocks Orai ..:

Li, Pengyun ; Rubaiy, Hussein N. ; Chen, Gui‐Lan...
British Journal of Pharmacology.  176 (2019)  19 - p. 3845-3856 , 2019
 
?
7

Treasure troves of pharmacological tools to study transient..:

Rubaiy, Hussein N.
British Journal of Pharmacology.  176 (2019)  7 - p. 832-846 , 2019
 
?
8

Tonantzitlolone is a nanomolar potency activator of transie..:

Rubaiy, Hussein N ; Ludlow, Melanie J ; Siems, Karsten...
British Journal of Pharmacology.  175 (2018)  16 - p. 3361-3368 , 2018
 
?
9

Identification of an (−)-englerin A analogue, which antagon..:

Rubaiy, Hussein N ; Seitz, Tobias ; Hahn, Sven...
British Journal of Pharmacology.  175 (2018)  5 - p. 830-839 , 2018
 
?
 
?
14

Natural and synthetic flavonoid modulation of TRPC5 channel:

Naylor, Jacqueline ; Minard, Aisling ; Gaunt, Hannah J...
British Journal of Pharmacology.  173 (2016)  3 - p. 562-574 , 2016
 
1-15